FCL Fineotex gains August 2026 AquaStrike manufacturing registration

FCL Fineotex said AquaStrike Premium received registration in August 2026 for manufacture at its Ambernath plant, alongside Haffkine Institute test reports on larvicidal and pupacidal activity. The disclosure adds an Indian manufacturing milestone for the mosquito life-cycle controller after overseas approvals or clearances cited by FCL Fineotex.

What Indian registration did FCL Fineotex receive for AquaStrike Premium?

FCL Fineotex said it received registration in August 2026 to manufacture AquaStrike Premium at the Ambernath plant. The presentation identifies AquaStrike Premium as a mosquito life-cycle controller and water-preservation additive. It describes the event as a manufacturing registration at a named plant, not as a sales approval, customer order, commercial launch or revenue contribution.

The August 2026 disclosure was accompanied by Haffkine Institute efficacy test reports for larvicidal and pupacidal activity. Those reports cover mosquito larvae and pupae, two stages in the product presentation’s life-cycle diagram. FCL Fineotex also markets AquaStrike Premium as effective against larvae, pupae and adult mosquitoes, but the specifically identified Haffkine reports concern larvae and pupae.

FCL Fineotex does not state Ambernath manufacturing capacity, product output, selling price, customer contracts or expected revenue from AquaStrike Premium. It also does not disclose the registration’s duration or conditions. The source therefore establishes a plant-specific manufacturing milestone, while leaving the timing and scale of Indian commercial sales unspecified.

How does AquaStrike Premium work according to FCL Fineotex?

FCL Fineotex describes AquaStrike Premium as a non-toxic, non-polluting and eco-friendly mosquito killer and water-preservation additive intended to eradicate the mosquito life cycle. Its presentation shows the cycle from adult and egg stages through four larval stages and a pupal stage. The stated mechanism is disruption across the life cycle rather than conventional mosquito-control methods.

FCL Fineotex says AquaStrike Premium is poured or sprinkled like water, rather than sprayed in gaseous form. It says a few drops are sufficient and presents this handling method as simpler than alternatives it identifies as BTI. The material does not provide a dosage per litre, treatment-area measurement, application frequency or product-use instructions for a particular water body.

The company describes AquaStrike Premium as non-smelly and invisible, and says it is safe for humans, animals and the environment. It also says NSF confirmed non-toxicity even in drinkable water. These are company product statements: the presentation does not provide the underlying NSF document, test conditions, dosing levels or comparative results against another mosquito-control treatment.

FCL Fineotex further labels AquaStrike Premium as “proven 100% efficient” against larvae, pupae and adult mosquitoes. The Haffkine Institute material named in the August 2026 update, however, is limited by description to larvicidal and pupacidal efficacy. The presentation provides no adult-mosquito test result, sample size, test period or field-study design for the broader 100% product claim.

Which overseas approvals has FCL Fineotex disclosed for AquaStrike Premium?

FCL Fineotex says AquaStrike Premium has been approved by Malaysia’s Ministry of Health, the Singapore Public Utility Board, bodies in Vietnam and Cambodia, and for shipment to Europe under EU approval. The company also says the product is produced in Malaysia with European design engineering. These statements form the overseas regulatory and production context cited alongside the August 2026 Ambernath registration.

A second AquaStrike Premium panel lists Malaysia’s Ministry of Health, Singapore HSA, Vietnam and Cambodia. The presentation uses two different Singapore designations, the Singapore Public Utility Board and Singapore HSA, without saying whether they represent separate approvals or different descriptions of the same regulatory position. It does not provide approval dates, registration numbers, use conditions or the names of the Vietnam and Cambodia bodies.

The European statement is narrower than a general product-registration claim because FCL Fineotex says there is approval for shipment to Europe. The presentation does not identify a member-state authorisation, distributor, import volume or sales date. It also says AquaStrike Premium will be under a WHO registration application, which indicates a planned application rather than a disclosed WHO registration.

Compared with the overseas references, the August 2026 Indian disclosure gives a specific date, a specific plant and a specific manufacturing purpose. The overseas statements identify several jurisdictions but provide no dates or manufacturing-site scope. FCL Fineotex does not state that overseas approvals automatically permit Indian manufacture or Indian market sales.

What opportunity does FCL Fineotex identify for AquaStrike Premium?

FCL Fineotex identifies water preservation, public health and environmental sustainability as the opportunity areas for AquaStrike Premium. The company links that opportunity to the product’s water-applied format and its stated ability to address mosquito development from larvae and pupae through adult mosquitoes. It also says multiple international approvals support a global market opportunity.

The presentation does not disclose a market-size estimate for mosquito life-cycle controllers, a target customer category, a target geography, market share or a sales target for AquaStrike Premium. This differs from FCL Fineotex’s cleaning-and-hygiene presentation, which cites a USD 2.1 billion Indian business-to-business and institutional specialty-chemicals market in 2024, projected to reach USD 4.5 billion by 2033. No equivalent quantified market forecast is supplied for AquaStrike Premium.

FCL Fineotex’s stated commercial case for AquaStrike Premium therefore rests on product positioning and regulatory progress rather than a quantified demand forecast. The source does not specify whether India rollout would target municipal water bodies, institutions, households, commercial operators or another segment. It also does not say whether Malaysian production will continue alongside Ambernath manufacture.

Conclusion

FCL Fineotex has disclosed an August 2026 manufacturing registration for AquaStrike Premium at Ambernath, supported by Haffkine Institute reports for larvicidal and pupacidal activity. The update is more specific than the company’s overseas references because it identifies both the Indian plant and the manufacturing purpose, while the supplied material does not establish commercial sales, output or revenue.

The next disclosed regulatory step is FCL Fineotex’s planned WHO registration application. Investors can watch for company disclosures on Ambernath capacity, Indian launch timing, intended customer segments, product-use conditions and any sales or revenue targets for AquaStrike Premium.